Late stage clinical development plan for cladribine tablets in the treatment of multiple sclerosis

被引：0
|
作者：
Viglietta, V. [1 ]
Greenberg, S. [1 ]
Mikol, D. [1 ]
Weiner, J. [1 ]
Alteri, E. [1 ]
Chang, P. [1 ]
Krumwieh, D. [1 ]
Musch, B. [1 ]
机构：
[1] Merck Serono SA, Geneva, Switzerland
来源：
JOURNAL OF NEUROLOGY | 2010年 / 257卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P443
引用
收藏
页码：S143 / S144
页数：2
相关论文
共 50 条
  • [1] Clinical development plan for cladribine tablets, an oral immunomodulator, for the treatment of multiple sclerosis
    Viglietta, V.
    Greenberg, S.
    Mikol, D.
    Weiner, J.
    Alteri, E.
    Chang, P.
    Krumwieh, D.
    Musch, B.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S126 - S126
  • [2] The Clinical Pharmacology of Cladribine Tablets for the Treatment of Relapsing Multiple Sclerosis
    Hermann, Robert
    Karlsson, Mats O.
    Novakovic, Ana M.
    Terranova, Nadia
    Fluck, Markus
    Munafo, Alain
    CLINICAL PHARMACOKINETICS, 2019, 58 (03) : 283 - 297
  • [3] The Clinical Pharmacology of Cladribine Tablets for the Treatment of Relapsing Multiple Sclerosis
    Robert Hermann
    Mats O. Karlsson
    Ana M. Novakovic
    Nadia Terranova
    Markus Fluck
    Alain Munafo
    Clinical Pharmacokinetics, 2019, 58 : 283 - 297
  • [4] The Development of Cladribine Tablets for the Treatment of Multiple Sclerosis: A Comprehensive Review
    Rammohan, Kottil
    Coyle, Patricia K.
    Sylvester, Elke
    Galazka, Andrew
    Dangond, Fernando
    Grosso, Megan
    Leist, Thomas P.
    DRUGS, 2020, 80 (18) : 1901 - 1928
  • [5] The Development of Cladribine Tablets for the Treatment of Multiple Sclerosis: A Comprehensive Review
    Kottil Rammohan
    Patricia K. Coyle
    Elke Sylvester
    Andrew Galazka
    Fernando Dangond
    Megan Grosso
    Thomas P. Leist
    Drugs, 2020, 80 : 1901 - 1928
  • [6] Cladribine Tablets' Potential in Multiple Sclerosis Treatment
    Costello, Kathleen
    Sipe, Jack C.
    JOURNAL OF NEUROSCIENCE NURSING, 2008, 40 (05) : 275 - 280
  • [7] Cladribine tablets in the treatment of patients with multiple sclerosis: an integrated analysis of safety from the multiple sclerosis clinical development program
    Cook, S.
    Leist, T.
    Comi, G.
    Montalban, X.
    Sylvester, E.
    Hicking, C.
    Dangond, F.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 305 - 306
  • [8] Expert Opinion on the Use of Cladribine Tablets in Clinical Practice for the Treatment of Relapsing Multiple Sclerosis
    Sorensen, Per Soelberg
    Centonze, Diego
    Giovannoni, Gavin
    Montalban, Xavier
    Selchen, Daniel
    Vermersch, Patrick
    Wiendl, Heinz
    Yamout, Bassem
    Salloukh, Hashem
    Rieckmann, Peter
    NEUROLOGY, 2020, 94 (15)
  • [9] Cladribine tablets for the treatment of relapsing-remitting multiple sclerosis
    Comi, Giancarlo
    Hartung, Hans-Peter
    Kurukulasuriya, Nuwan C.
    Greenberg, Steven J.
    Scaramozza, Matthew
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (01) : 123 - 136
  • [10] Safety and tolerability of cladribine tablets in multiple sclerosis: the CLARITY (CLAdRIbine Tablets treating multiple sclerosis orallY) study
    Cook, S.
    Vermersch, P.
    Comi, G.
    Giovannoni, G.
    Rammohan, K.
    Rieckmann, P.
    Sorensen, P. Soelberg
    Hamlett, A.
    Miret, M.
    Weiner, J.
    Viglietta, V.
    Musch, B.
    Greenberg, S. J.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 (05) : 578 - 593
12345